Global API Outlook: Will Supply Lines Change Amid Tariff Uncertainty? 
By

By
As evolving US trade policy looms, what are the demand–supply fundamentals now in the global market for active pharmaceutical ingredients (APIs)?  A look at the demand side—size, growth rates, and…

Biomanufacturing: How are Industry Capacity & Supply Chains Trending?
By

By
What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies, and is there too much capacity or is the market tight? Is biomanufacturing outsourcing…

Parenteral Drug Manufacturing—CDMO Outlook: A Capacity Crunch or Easing?
By

By
What is the supply and demand outlook for fill–finish capacity in the CDMO/CMO sector? Is a capacity crunch or capacity ease in the making? And how will hot-product areas, such…

Bio/Pharma Industry Outlook, Supply Chains 2025: The Year Ahead
By

By
What will be the key issues shaping bio/pharma supply chains in 2025? Looking at the impact of potential changes in US tariff and trade policy. Plus, what lies ahead in…